$38.77
11.79% yesterday
Nasdaq, Aug 11, 10:00 pm CET
ISIN
US38870X1046
Symbol
LENZ

Graphite Bio Inc Target price 2025 - Analyst rating & recommendation

Graphite Bio Inc Classifications & Recommendation:

Buy
93%
Hold
7%

Graphite Bio Inc Price Target

Target Price $53.04
Price $38.77
Potential
Number of Estimates 9
9 Analysts have issued a price target Graphite Bio Inc 2026 . The average Graphite Bio Inc target price is $53.04. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 13 Analysts recommend Graphite Bio Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Graphite Bio Inc stock has an average upside potential 2026 of . Most analysts recommend the Graphite Bio Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 0.00 7.83

10 Analysts have issued a sales forecast Graphite Bio Inc 2025 . The average Graphite Bio Inc sales estimate is

$7.8m
Unlock
. This is
56.52% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$11.9m 137.94%
Unlock
, the lowest is
$5.9m 17.60%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $0.0
2026
$51.4m 556.26%
Unlock
2027
$129m 151.02%
Unlock

4 Analysts have issued an Graphite Bio Inc EBITDA forecast 2025. The average Graphite Bio Inc EBITDA estimate is

$-79.0m
Unlock
. This is
27.72% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-79.9m 29.06%
Unlock
, the lowest is
$-77.3m 24.96%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-58.6m 17.19%
2025
$-79.0m 34.96%
Unlock
2026
$-72.0m 8.94%
Unlock
2027
$1.9m 102.58%
Unlock

EBITDA Margin

2026
-140.11% 86.12%
Unlock
2027
1.44% 101.03%
Unlock

10 Graphite Bio Inc Analysts have issued a net profit forecast 2025. The average Graphite Bio Inc net profit estimate is

$-82.9m
Unlock
. This is
58.15% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-76.9m 46.77%
Unlock
, the lowest is
$-85.2m 62.58%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-49.8m 60.07%
2025
$-82.9m 66.51%
Unlock
2026
$-79.4m 4.22%
Unlock
2027
$-22.2m 71.98%
Unlock

Net Margin

2026
-154.54% 85.41%
Unlock
2027
-17.25% 88.84%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -2.34 -2.91
84.71% 24.36%
P/E negative
EV/Sales 114.53

10 Analysts have issued a Graphite Bio Inc forecast for earnings per share. The average Graphite Bio Inc EPS is

$-2.91
Unlock
. This is
56.45% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-2.70 45.16%
Unlock
, the lowest is
$-2.99 60.75%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-2.34 84.71%
2025
$-2.91 24.36%
Unlock
2026
$-2.78 4.47%
Unlock
2027
$-0.78 71.94%
Unlock

P/E ratio

Current -20.84 147.18%
2025
-13.33 36.05%
Unlock
2026
-13.92 4.43%
Unlock
2027
-49.68 256.90%
Unlock

Based on analysts' sales estimates for 2025, the Graphite Bio Inc stock is valued at an EV/Sales of

114.53
Unlock
and an P/S ratio of
141.30
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 179.26
2025
114.53 36.11%
Unlock
2026
17.45 84.76%
Unlock
2027
6.95 60.16%
Unlock

P/S ratio

Current
2025
141.30 36.11%
Unlock
2026
21.53 84.76%
Unlock
2027
8.58 60.16%
Unlock

Current Graphite Bio Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citigroup
Locked
Locked
Locked Aug 01 2025
HC Wainwright & Co.
Locked
Locked
Locked Aug 01 2025
Citigroup
Locked
Locked
Locked Jul 31 2025
Raymond James
Locked
Locked
Locked Jul 31 2025
HC Wainwright & Co.
Locked
Locked
Locked Jul 28 2025
HC Wainwright & Co.
Locked
Locked
Locked May 08 2025
HC Wainwright & Co.
Locked
Locked
Locked Apr 16 2025
Analyst Rating Date
Locked
Citigroup:
Locked
Locked
Aug 01 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Aug 01 2025
Locked
Citigroup:
Locked
Locked
Jul 31 2025
Locked
Raymond James:
Locked
Locked
Jul 31 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jul 28 2025
Locked
HC Wainwright & Co.:
Locked
Locked
May 08 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Apr 16 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today